Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Hina Budhwani
483
•Hina Budhwani•October 24, 2025

Hina Budhwani – FDA 483, Oct 24, 2025

Record Details

An FDA inspection of Hina S. Budhwani, MD, Clinical Investigator in Houston, TX, revealed one observation related to the conduct of an investigation. The firm failed to adhere to the investigational plan by not maintaining the required waiting period between doses for subjects in a clinical protocol. This indicates a deviation from established study procedures.

Company
Hina Budhwani
Inspection date
October 24, 2025
Product type
drugs
Office
Dallas District Office
Person
  • Habacuc V. Barrera
View Company Profile

ID · 4dc5ffd6-1b0f-44f5-b4de-f7a557b7eea6

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Hina Budhwani
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.